1Cademy - Results: Treatment of COVID-19 Patients with Quercetin: A Prospective, Single

Concept

Results: Treatment of COVID-19 Patients with Quercetin: A Prospective, Single - Centre, Randomized, Controlled Trial.

No adverse effects related to the QCB supplementation in patients found
Significantly greater decrease in biomarkers for COVID-19 including, C-reactive protein, procalcitonin and ferritin, was observed in the group that received the QCB supplementation.
Significantly greater increase in thrombocyte and lymphocyte count was observed in group that received QCB supplementation.
QCB found to be effective in the treatment of COVID-19

Updated 2021-03-05

Contributors are:

Who are from:

References